Functional impacts of the diversity of the meningococcal factor H binding protein

Eva Hong1, Dario Giorgini, Ala-Eddine Deghmane

  • 1Institut Pasteur, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci, 28 Rue du Dr Roux, 75724 Paris Cedex 15, France.

Vaccine
|November 6, 2012
PubMed

Insights

Meningococcal factor H binding protein (fHbp) shows significant genetic diversity, impacting its interaction with human factor H and complement C3b deposition. However, anti-fHbp antibodies effectively kill bacteria, requiring a minimum fHbp surface level.

Area of Science:

  • Bacteriology
  • Immunology
  • Vaccine Development

Background:

  • Neisseria meningitidis causes severe invasive infections.
  • Meningococcal factor H binding protein (fHbp) aids bacterial survival by interacting with human factor H.
  • fHbp is a key target for developing new meningococcal vaccines.

Purpose of the Study:

  • To investigate the sequence diversity of the fhbp gene in Neisseria meningitidis.
  • To assess the impact of fHbp diversity on factor H binding and complement deposition.
  • To evaluate the efficacy of anti-fHbp antibodies in bacterial killing.

Main Methods:

  • DNA sequencing of the fhbp gene from 680 meningococcal isolates.
  • ELISA and flow cytometry to quantify surface fHbp levels.
  • Analysis of fHbp-factor H interactions and C3b complement deposition.

Main Results:

  • Significant sequence diversity in fHbp, particularly in factor H-binding regions.
  • fHbp allele distribution varied across meningococcal serogroups and clonal complexes.
  • Diversity affected factor H binding and C3b deposition, but anti-fHbp antibody-mediated killing remained effective above a threshold fHbp level.

Conclusions:

  • fHbp sequence diversity influences meningococcal pathogenesis and immune evasion strategies.
  • Characterizing fHbp diversity is crucial for understanding meningococcal evolution and vaccine efficacy.
  • Minimum fHbp surface levels are essential for bacterial survival and antibody-mediated killing.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...